Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

2.5K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.5K
Cancer Therapies02:49

Cancer Therapies

10.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.7K
Cancer Therapies02:49

Cancer Therapies

3.0K
3.0K
Cancer Vaccines01:30

Cancer Vaccines

1.4K
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
1.4K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

9.2K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.2K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

1.8K
1.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Oncolymphology: Immune Interactions and Cancer.

Lymphology·2023
Same author

Integrin alphavbeta3 mediates K1735 murine melanoma cell motility in vivo and in vitro.

Journal of cell science·2001
Same author

Early experience with sentinel lymph node mapping for Merkel cell carcinoma.

Journal of the American Academy of Dermatology·2001
Same author

Micrometastasis to in-transit lymph nodes from extremity and truncal malignant melanoma.

Annals of surgical oncology·2001
Same author

Evaluation of sentinel lymph node status in spindle cell melanomas.

Journal of the American Academy of Dermatology·2001
Same author

Principles and controversies in lymphoscintigraphy with emphasis on breast cancer.

The Surgical clinics of North America·2001
Same journal

Do Differences in Patient-Reported Outcome Measures for Robot-Assisted and Navigated Unicompartmental Knee Replacement Achieve Minimal Clinically Important Differences?

Surgical technology international·2025
Same journal

Clinical and Radiological Results of the Integrated Acetabular MUTARS® RS Cup System in the Revision of Geriatric Patients.

Surgical technology international·2025
Same journal

Does Robotic-Assisted Functional Knee Positioning Result in Better Functional Outcomes One Year After Surgery.

Surgical technology international·2025
Same journal

One-Year Clinical Outcomes Following Anterior Cruciate Ligament Reconstruction Augmented with a Reinforced Bioinductive Implant.

Surgical technology international·2025
Same journal

In-Office Skin Grafting for Lower Extremity Wounds.

Surgical technology international·2025
Same journal

Revision ACL Reconstruction with Hamstring Autograft from the Contralateral Leg With and Without Internal Brace: A Comparative Study.

Surgical technology international·2025
See all related articles

Related Experiment Video

Updated: Apr 12, 2026

Monitoring the Cancer-Immunity Cycle and Exploring Tumor Microenvironment Dynamics
12:19

Monitoring the Cancer-Immunity Cycle and Exploring Tumor Microenvironment Dynamics

Published on: June 7, 2024

2.2K

Immunotherapy for cancer.

S P Leong1

  • 1University of California / Mt. Zion Medical Center, San Francisco, California.

Surgical Technology International
|May 8, 2015
PubMed
Summary
This summary is machine-generated.

Immunotherapy shows promise for cancers like melanoma and renal cell carcinoma, especially when tumor burden is minimal. Reducing tumors through surgery or other therapies enhances immunotherapy

More Related Videos

Flow Cytometry-Based Isolation and Therapeutic Evaluation of Tumor-Infiltrating Lymphocytes in a Mouse Model of Pancreatic Cancer
07:55

Flow Cytometry-Based Isolation and Therapeutic Evaluation of Tumor-Infiltrating Lymphocytes in a Mouse Model of Pancreatic Cancer

Published on: January 17, 2025

2.0K
Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine
09:15

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

4.2K

Related Experiment Videos

Last Updated: Apr 12, 2026

Monitoring the Cancer-Immunity Cycle and Exploring Tumor Microenvironment Dynamics
12:19

Monitoring the Cancer-Immunity Cycle and Exploring Tumor Microenvironment Dynamics

Published on: June 7, 2024

2.2K
Flow Cytometry-Based Isolation and Therapeutic Evaluation of Tumor-Infiltrating Lymphocytes in a Mouse Model of Pancreatic Cancer
07:55

Flow Cytometry-Based Isolation and Therapeutic Evaluation of Tumor-Infiltrating Lymphocytes in a Mouse Model of Pancreatic Cancer

Published on: January 17, 2025

2.0K
Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine
09:15

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

4.2K

Area of Science:

  • Immunology
  • Oncology
  • Cancer Research

Background:

  • Significant advancements in cellular and molecular immunology.
  • The immune system's role in infection is clear; its role in cancer immune surveillance is under investigation.
  • The immune system is thought to interact with and regulate tumor growth.

Purpose of the Study:

  • To explore the application of immunotherapy in fighting tumors.
  • To identify cancers that show a response to immunotherapy.
  • To determine optimal conditions for immunotherapy efficacy.

Main Methods:

  • Review of immunotherapeutic approaches in various cancers.
  • Observation of responses in malignant melanoma and renal cell carcinoma.
  • Analysis of the relationship between tumor burden and immunotherapy effectiveness.

Main Results:

  • Immunotherapy has shown occasional, definitive responses in malignant melanoma and renal cell carcinoma.
  • Immune eradication of tumors is most effective when the tumor burden is minimal.
  • Immunotherapy may be most effective for controlling microscopic disease.

Conclusions:

  • Reducing tumor burden to a microscopic level is crucial for maximizing immunotherapy effects.
  • Combining immunotherapy with surgery, chemotherapy, or radiation therapy is a potential strategy.
  • Development of more potent vaccines and enhanced effector cell stimulation is needed for optimal tumor cell eradication.